Skip to main content
TipRanks
Go Ultimate75% OFF

The United Laboratories International Holdings (3933) Stock Statistics & Valuation Metrics

7 Followers

Total Valuation

The United Laboratories International Holdings has a market cap or net worth of HKD 14.22B. The enterprise value is HKD 10.04B.

Market Cap
HKD 14.22B
Enterprise Value
HKD 10.04B

Share Statistics

The United Laboratories International Holdings has 1,970,276,500 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
1,970,276,500
Owned by Insiders
―
Owned by Institutions
8.23%

Financial Efficiency

The United Laboratories International Holdings’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 8.15%.

Return on Equity (ROE)
0.12
Return on Assets (ROA)
0.07
Return on Invested Capital (ROIC)
8.15%
Return on Capital Employed (ROCE)
0.11
Revenue Per Employee
733.92K
Profits Per Employee
115.88K
Employee Count
18,000
Asset Turnover
0.43
Inventory Turnover
3.25

Valuation Ratios

The current PE Ratio of The United Laboratories International Holdings is 21.95. The United Laboratories International Holdings’s PEG ratio is -0.26.

PE Ratio
21.95
PS Ratio
1.01
PB Ratio
0.70
Price to FCF
50.82
Price to Operating Cash Flow
6.59
PEG Ratio
-0.26

Income Statement

In the last 12 months, The United Laboratories International Holdings had revenue of 13.21B and earned 2.09B in profits. Earnings per share was 1.11.

Revenue
13.21B
Gross Profit
5.51B
Operating Income
2.27B
Pretax Income
2.53B
Net Income
2.09B
EBITDA
2.87B
Earnings Per Share (EPS)
1.11

Cash Flow

In the last 12 months, operating cash flow was 1.83B and capital expenditures -1.59B, giving a free cash flow of 236.66M billion.

Operating Cash Flow
1.83B
Free Cash Flow
236.66M
Free Cash Flow per Share
0.12

Dividends & Yields

The United Laboratories International Holdings pays an annual dividend of HKD 0.30, resulting in a dividend yield of 6.57%

Dividend Per Share
HKD 0.30
Dividend Yield
6.57%
Payout Ratio
35.48%
Free Cash Flow Yield
1.98%
Earnings Yield
4.50%

Stock Price Statistics

Beta
1.08
52-Week Price Change
-40.22%
50-Day Moving Average
7.54
200-Day Moving Average
9.04
Relative Strength Index (RSI)
42.68
Average Volume (3m)
5.64M

Important Dates

The United Laboratories International Holdings upcoming earnings date is Mar 30, 2027, TBA (Not Confirmed).

Last Earnings Date
Aug 31, 2026
Next Earnings Date
Mar 30, 2027
Ex-Dividend Date
Jul 07, 2026

Financial Position

The United Laboratories International Holdings as a current ratio of 1.83, with Debt / Equity ratio of 28.70%

Current Ratio
1.83
Quick Ratio
1.60
Debt to Market Cap
0.25
Net Debt to EBITDA
-2.18
Interest Coverage Ratio
32.58

Taxes

In the past 12 months, The United Laboratories International Holdings has paid 446.87M in taxes.

Income Tax
446.87M
Effective Tax Rate
0.18

Enterprise Valuation

The United Laboratories International Holdings EV to EBITDA ratio is 4.83, with an EV/FCF ratio of 26.15.

EV to Sales
0.52
EV to EBITDA
4.83
EV to Free Cash Flow
26.15
EV to Operating Cash Flow
3.39

Balance Sheet

The United Laboratories International Holdings has HKD 11.73B in cash and marketable securities with HKD 5.95B in debt, giving a net cash position of HKD 5.78B billion.

Cash & Marketable Securities
HKD 11.73B
Total Debt
HKD 5.95B
Net Cash
HKD 5.78B
Net Cash Per Share
HKD 2.93
Tangible Book Value Per Share
HKD 8.61

Margins

Gross margin is 31.28%, with operating margin of 4.64%, and net profit margin of 4.55%.

Gross Margin
31.28%
Operating Margin
4.64%
Pretax Margin
4.84%
Net Profit Margin
4.55%
EBITDA Margin
10.80%
EBIT Margin
4.48%

Analyst Forecast

The average price target for The United Laboratories International Holdings is HKD 10.85, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
HKD 10.85
Price Target Upside
51.78% Upside
Analyst Consensus
Strong Buy
Analyst Count
4
Revenue Growth Forecast
-12.86%
EPS Growth Forecast
-83.10%

Scores

Smart Score
3
AI Score
58.2